MetaCap

Amylyx Pharmaceuticals Congress Trades

NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.14+0.94 (+3.46%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0
Sales
0
Politicians trading
0
Latest trade
Oct 12, 2022

Amylyx Pharmaceuticals Congress trading summary

Members of Congress have disclosed 1 transaction in Amylyx Pharmaceuticals (AMLX) stock, reported by 1 politician. No AMLX trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Chris Jacobs (1).

The latest reported trade is a purchase by Chris Jacobs dated Oct 12, 2022 and disclosed on Nov 16, 2022. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.

Summary generated from market data by MetaCap's automated system. Methodology

Politicians trading AMLX

AMLX trades by members of Congress

Amylyx Pharmaceuticals stock trades disclosed by members of Congress
PoliticianTypeAmountTradedFiling
Chris Jacobs official portraitChris JacobsR-NYHouseBuy$1,001 – $15,000Oct 12, 2022Filing for Chris Jacobs AMLX trade

Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.

Related

Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell AMLX. How Congress trading data works